A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02174172 · COMPLETED
Trial details
- NCT number
- NCT02174172
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-18
- Primary completion
- 2019-11-25
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.